iShares STOXX Europe 50 UCITS ETF EUR (Dist) CHF is a equity ETF from iShares tracking the STOXX Europe 50 index through physical replication. Domiciled in Ireland and launched in 2000, the fund manages about 578 M € and charges a TER of 0.35% — 35 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
iShares STOXX Europe 50 UCITS ETF EUR (Dist) CHF competes with 261 other products in the same class and region (Equity, Europe): it ranks 73rd by fund size and 215th by ongoing cost, with a TER of 0.35% against a group median of 0.25%. It has been listed since 2000, 26 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 35 € a year, against 25 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 40.3% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| ASML Holding N.V. | 10.0% |
| HSBC Holdings PLC | 4.3% |
| Novartis AG | 3.9% |
| AstraZeneca PLC | 3.8% |
| Roche Holding AG | 3.8% |
| Nestle S.A. | 3.5% |
| Siemens Aktiengesellschaft | 3.1% |
| Shell plc | 2.8% |
| Banco Santander S.A. | 2.6% |
| Schneider Electric S.E. | 2.5% |
| Borsa Italiana | EUN | EUR |
| XETRA | EUN1 | EUR |
| Francoforte | EUN1 | EUR |
| London Stock Exchange | EUN | GBX |
| SIX Swiss Exchange | EUN | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.